Acquired VLDL receptor deficiency in experimental nephrosis

Kidney International

Volumn 51, Issue 6, 1997, Pages 1761-1765

  Liang, Kaihui ^a   Vaziri, Nosratola D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PUROMYCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; NEPHROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

EID: 0030964202     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.242     Document Type: Article

References (18)

1. VAZIRI ND, LIANG KH: Hepatic HMG-CoA reductase gene expression in the course of puromycin-induced nephrosis. Kidney Int 48: 1979-1985, 1995
2. LIANG KH, OVEISI F, VAZIRI ND: Gene expression of hepatic cholesterol 7α-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int 49:855-860, 1996
3. VAZIRI ND, LIANG KH: Down regulation of hepatic LDL receptor in experimental nephrosis. Kidney Int 50:887-893, 1996
4. LIANG K, VAZIRI ND: Gene expression of lipoprotein lipase in experimental nephrosis. J Lab Clin Med (in press)
5. KAYSEN GA: Hyperlipidemia of the nephrotic syndrome. Kidney Int 39(Suppl 31):S8-S15, 1991
6. JOVEN J, VILLABONA C, VILELLA E, MASANA L, ALBERTI R, VALLES M: Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 323:579-584, 1990
7. KRONENBERG F, UTERMAN G, DIEPLINGER H: Lipoprotein (a) in renal diseases. Am J Kidney Dis 27:1-25, 1996
8. TAKAHASHI S, KAWARABAYASI Y, NAKAI T, SAKAI J, YAMAMOTO T: Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256, 1992
9. JOKINEN EV, LANDSCHULZ KT, WYNE KL, HO YK, FRYKMAN PK, HOBBS HH: Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 269:26411-26418, 1994
10. WEBB JC, PATEL DD, JONES MD, KNIGHT BL, SOUTAR AK: Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum Mol Gen 3:531-537, 1994
11. GAFVELS ME, CAIRD M, BRITT D, JACKSON CL, PATTERSON D, STRAUSS JF: Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. Somatic Cell Mol Genet 19:557-569, 1993
12. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
13. VAZIRI ND, LIANG K: Down regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int 51:913-919, 1997
14. VAZIRI ND: Endocrinological consequences of nephrotic syndrome. Am J Nephrol 13:360-364, 1993
15. AFRASIABI MA, VAZIRI ND, GWINUP G, MAYS M, BARTON CH, NESS R, VALENTA LJ: Thyroid function studies in the nephrotic syndrome. Ann Intern Med 90:335-338, 1979
16. VAZIRI ND, LIANG K: Down regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int 50:1928-1935, 1996
17. AKMAL M, KASIM SE, SOLIMAN AR, MASSRY SG: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37:854-858, 1990
18. KLIN M, SMOGORZEWSKI M, NI Z, ZHANG G, MASSRY SG: Abnormalities in hepatic lipase in chronic renal failure: Role of excess parathyroid hormone. J Clin Invest 97:2167-2173, 1996